pH modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside

E Culebras1, J L Martínez, F Baquero

  • 1Centro Nacional de Biotecnología,(CSIC), Cantoblanco, Madrid, Spain.

Insights

The enzyme AAC(6’)IV activity varies with aminoglycoside structure and pH. Glucosamine antibiotics show pH-dependent inhibition, unlike garosamine compounds, impacting bacterial resistance.

Area of Science:

  • Microbiology
  • Enzymology
  • Pharmacology

Background:

  • Aminoglycoside antibiotics are crucial for treating bacterial infections.
  • Enzymatic modification is a key mechanism of aminoglycoside resistance.
  • The enzyme 6'-N-aminoglycoside acetyltransferase (AAC(6')IV) confers resistance by acetylating aminoglycosides.

Purpose of the Study:

  • To investigate the kinetic properties of AAC(6')IV from Staphylococcus epidermidis RYC 13036.
  • To determine how substrate structure (aminosugar moiety) and pH affect enzyme activity and inhibition.
  • To correlate enzyme kinetics with observed minimum inhibitory concentrations (MICs) of aminoglycosides.

Main Methods:

  • Enzyme kinetics assays using tobramycin, amikacin, gentamicin, and netilmicin as substrates.
  • Measurement of kinetic constants (e.g., Km, Vmax) under varying pH conditions.
  • Determination of substrate inhibition patterns and their pH dependence.

Main Results:

  • AAC(6')IV exhibited different kinetic constants for glucosamine-containing (tobramycin, amikacin) versus garosamine-containing (gentamicin, netilmicin) aminoglycosides.
  • Glucosamine acetylation was highly susceptible to substrate inhibition, which increased with pH.
  • Garosamine acetylation showed limited substrate inhibition across a broad pH range.
  • Observed kinetic differences correlated with the MIC values of S. epidermidis RYC 13036 against these aminoglycosides.

Conclusions:

  • The aminosugar moiety of aminoglycosides and environmental pH significantly influence AAC(6')IV-substrate interactions.
  • These factors modulate enzyme activity and contribute to the varying efficacy of aminoglycosides against S. epidermidis.
  • Understanding these interactions is vital for predicting and overcoming aminoglycoside resistance.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...